---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-271609"
form_type: "8-K"
ticker: "IKT"
cik: "0001750149"
company_name: "Inhibikase Therapeutics, Inc."
filed_at: "2024-12-05T23:59:59+00:00"
generated_at: "2026-05-29T07:20:35.120155+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Inhibikase terminates unused ATM facility; no impact on capital

## Summary
- Terminated ATM agreement with H.C. Wainwright effective Dec 11, 2024.
- Original ATM limit was $5.66M; only $849k sold before reduction to $50k.
- No shares sold under ATM since May 20, 2024.
- Termination ends ability to issue equity at market via this facility.

## SEC filing metadata
- accession: 0001193125-24-271609
- form_type: 8-K
- ticker: IKT
- cik: 0001750149
- company_name: Inhibikase Therapeutics, Inc.
- filed_at: 2024-12-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750149/000119312524271609/0001193125-24-271609-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750149/000119312524271609/d914736d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-271609
- JSON: https://secwatch.observer/filing/0001193125-24-271609.json
- Plain text: https://secwatch.observer/filing/0001193125-24-271609.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.